Table 2.

Proportion of patient-days with exposure to time-varying covariates

Time-varying exposure	Percentage of days of follow-up with exposure
Trimethoprim-sulfamethoxazole	24.7 %
Azithromycin	12.0 %
HAART	77.1 %
Catheter	1.6 %
Public Aid	79.8 %
Viral load
<1000 copies/mL	60.0 %
1000+ copes/mL	40.0 %
CD4
<50 cells/mL	6.5 %
50–99 cells/mL	4.0 %
100+ cells/mL	89.5 %
Cancer	7.8 %
Diabetes	14.6 %
End-stage renal disease	11.5 %